Monocyte apoptosis in patients with active lupus

Arthritis and Rheumatism

Volumn 39, Issue 8, 1996, Pages 1432-1434

  Richardson, Bruce C ^a   Yung, Raymond L ^a   Johnson, Kent J ^a   Rowse, Paul E ^b   Lalwani, Narendra D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; METHYLPREDNISOLONE;

APOPTOSIS; ARTICLE; CHROMATIN; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MONOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0029781757     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390827     Document Type: Article

References (15)

1. Rumore PM, Steinman CR: Endogenous circulating DNA in systemic lupus erythematosus. J Clin Invest 86:69-74, 1990
2. Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685-3692, 1994
3. Richardson BC, Strahler JR, Pivirotto TS, Quddus J, Bayliss GE, Gross LA, O'Rourke KS, Powers D, Hanash SM, Johnson MA: Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35:647-662, 1992
4. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC: Mechanisms of drug induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 154:3025-3035, 1995
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
7. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275-285, 1992
8. Telford WG, King LE, Fraker PJ: Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13:137-143, 1992
9. Quismorio FP Jr: Hemic and lymphatic abnormalities in SLE. In, Dubois' Lupus Erythematosus. Fourth edition. Edited by DJ Wallace, BH Hahn. Philadelphia, Lea and Febiger, 1993
10. Klemperer P, Gueft B, Lee SL, Leuchtenberger C, Pollister AW: Cytochemical changes of acute lupus erythematosus. Arch Pathol Lab Med 49:503-516, 1950
11. Cohen AH, Zamboni L: Ultrastructural appearance and morphogenesis of renal glomerular hematoxylin bodies. Am J Pathol 89:105-118, 1977
12. Richardson BC, Lalwani ND, Johnson KJ, Marks RM: Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 24:2640-2645, 1994
13. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB: Apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034, 1994
14. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
15. Burlingame RW, Boey ML, Starkebaum G, Rubin RL: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184-192, 1994